Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 20;12(12):4152.
doi: 10.3390/jcm12124152.

Intraoperative Visualization and Treatment of Salivary Gland Dysfunction in Sjögren's Syndrome Patients Using Contrast-Enhanced Ultrasound Sialendoscopy (CEUSS)

Affiliations

Intraoperative Visualization and Treatment of Salivary Gland Dysfunction in Sjögren's Syndrome Patients Using Contrast-Enhanced Ultrasound Sialendoscopy (CEUSS)

K Hakki Karagozoglu et al. J Clin Med. .

Abstract

In sialendoscopy, ducts are dilated and the salivary glands are irrigated with saline. Contrast-enhanced ultrasound sialendoscopy (CEUSS), using microbubbles, may facilitate the monitoring of irrigation solution penetration in the ductal system and parenchyma. It is imperative to test CEUSS for its safety and feasibility in Sjögren's syndrome (SS) patients. CEUSS was performed on 10 SS patients. The primary outcomes were safety, determined by the occurrence of (serious) adverse events ((S)AEs), and feasibility. The secondary outcomes were unstimulated and stimulated whole saliva (UWS and SWS) flow rates, xerostomia inventory (XI), clinical oral dryness score, pain, EULAR Sjögren's syndrome patient reported index (ESSPRI), and gland topographical alterations. CEUSS was technically feasible in all patients. Neither SAEs nor systemic reactions related to the procedure were observed. The main AEs were postoperative pain (two patients) and swelling (two patients). Eight weeks after CEUSS, the median UWS and SWS flow had increased significantly from 0.10 to 0.22 mL/min (p = 0.028) and 0.41 to 0.61 mL/min (p = 0.047), respectively. Sixteen weeks after CEUSS, the mean XI was reduced from 45.2 to 34.2 (p = 0.02). We conclude that CEUSS is a safe and feasible treatment for SS patients. It has the potential to increase salivary secretion and reduce xerostomia, but this needs further investigation.

Keywords: Sjogren’s syndrome; Sjögren’s syndrome; endoscopy; microbubbles; saliva; sialendoscopy; ultrasound; xerostomia.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of the allocation of participants.
Figure 2
Figure 2
Images of (A) left parotid gland with complete homogeneous dense penetration of microbubbles. (B) Right submandibular gland (SMG) with complete, inhomogeneous dense penetration of microbubbles. (C) Right parotid gland with complete homogenous penetration of microbubbles with moderate density. (D) Left SMG with no penetration of microbubbles. Only the main duct is visible. Yellow areas: microbubbles; Arrow: Wharton’s duct. Please note: the images are from four different patients.

References

    1. Fox R.I. Sjögren’s syndrome. Lancet. 2005;366:321–331. doi: 10.1016/S0140-6736(05)66990-5. - DOI - PubMed
    1. Kroese F.G., Abdulahad W.H., Haacke E., Bos N.A., Vissink A., Bootsma H. B-cell hyperactivity in primary Sjögren’s syndrome. Expert Rev. Clin. Immunol. 2014;10:483–499. doi: 10.1586/1744666X.2014.891439. - DOI - PubMed
    1. Qin B., Wang J., Yang Z., Yang M., Ma N., Huang F., Zhong R. Epidemiology of primary Sjögren’s syndrome: A systematic review and meta-analysis. Ann. Rheum. Dis. 2015;74:1983–1989. doi: 10.1136/annrheumdis-2014-205375. - DOI - PubMed
    1. Mariette X., Criswell L.A. Primary Sjögren’s Syndrome. N. Engl. J. Med. 2018;379:97. doi: 10.1056/NEJMcp1702514. - DOI - PubMed
    1. Pijpe J., Kalk W.W., Bootsma H., Spijkervet F.K., Kallenberg C.G., Vissink A. Progression of salivary gland dysfunction in patients with Sjogren’s syndrome. Ann. Rheum. Dis. 2007;66:107–112. doi: 10.1136/ard.2006.052647. - DOI - PMC - PubMed

LinkOut - more resources